How many studies have been conducted on Apolipoprotein L1?

BiohacksAI has indexed 300 PubMed studies on Apolipoprotein L1, including 1 randomized controlled trials (RCTs). 39% of studies involve human subjects.

What are the main research areas for Apolipoprotein L1?

The primary research domains for Apolipoprotein L1 are 🫘 Kidney, ❤️ Cardiovascular, 🔥 Metabolic. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Apolipoprotein L1

An ApoL protein highly expressed by the liver. It has anti-trypanosomal activity through its ability to permeabilize TRYPANOSOMA membranes. Mutations in the APOL1 gene are associated with type 4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS .

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 47

Research Domains

Apolipoprotein L1 has been studied across 15 research domains including 🫘 Kidney, ❤️ Cardiovascular, 🔥 Metabolic, 🔬 Oncology, 🛡️ Immunity. The primary research focus is 🫘 Kidney with 60% of studies addressing this area.

Loading evidence profile...

This evidence profile for Apolipoprotein L1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.